Kenneth Clark
Direktor/Vorstandsmitglied bei SUMMIT THERAPEUTICS INC.
Vermögen: - $ am 30.04.2024
Profil
Kenneth A.
Clark is currently a Non-Executive Director at Summit Therapeutics Ltd.
and an Independent Non Executive Director at Summit Therapeutics, Inc. He is also a Partner at Wilson Sonsini Goodrich & Rosati PC since 1993.
Previously, he served as an Independent Director at Pharmacyclics LLC from 2012 to 2015 and at Pulse Biosciences, Inc. from 2017 to 2021.
Mr. Clark received his undergraduate degree from Vanderbilt University and his graduate degree from The University of Texas at Austin.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
SUMMIT THERAPEUTICS INC
-.--% | 17.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Kenneth Clark
Unternehmen | Position | Beginn |
---|---|---|
SUMMIT THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 07.10.2021 |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01.01.1993 |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kenneth Clark
Unternehmen | Position | Ende |
---|---|---|
PULSE BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 05.10.2021 |
PHARMACYCLICS, INC. | Direktor/Vorstandsmitglied | 01.05.2015 |
Ausbildung von Kenneth Clark
Vanderbilt University | Undergraduate Degree |
The University of Texas at Austin | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PULSE BIOSCIENCES, INC. | Health Technology |
SUMMIT THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Commercial Services |
Pharmacyclics LLC
Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |